HMG (75iu)

HMG (75 IU) protocols involve this injectable gonadotropin preparation containing a balanced mixture of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). It is primarily used in clinical settings to support reproductive hormone activity, including stimulation of gonadal function. HMG is commonly used under medical supervision for fertility-related protocols in both males and females.

Reconstitution: Add bacteriostatic water or sterile diluent as directed → concentration varies by dilution volume
Typical use: Administered in small, clinically guided doses (subcutaneous or intramuscular)
Administration: Frequency and dose are individualized based on hormonal response
Storage: Lyophilized powder: store at 2–8 °C or frozen as directed; after reconstitution, refrigerate and use within the recommended period

Concise summary of the regimen.

Goal: Support gonadal function through FSH and LH activity
Schedule: Intermittent injections based on hormone levels and treatment plan
Dose Range: Clinically determined; varies widely depending on indication
Monitoring: Hormonal response and lab testing are typically required

Suggested clinical approach for the 75 IU vial format.

Start: Determined by the healthcare provider based on baseline hormone status
Adjustment: Dose is modified according to response and lab results
Frequency: Commonly administered multiple times per week or as part of a structured cycle
Duration: Treatment cycles vary depending on the therapeutic goal
Important Note: Use only under medical supervision due to hormonal complexity

HMG (human menopausal gonadotropin) contains both FSH and LH activity derived from purified urinary sources. FSH primarily stimulates follicular development in the ovaries and supports spermatogenesis in the testes, while LH supports testosterone production in males and ovulation in females.

By providing exogenous gonadotropic stimulation, HMG helps regulate and enhance endogenous reproductive hormone function. This dual hormonal activity makes it useful in protocols where both follicular development and gonadal steroid production need support.

Observations based on clinical use in reproductive medicine.

Potential Benefits:

May support ovulation in females under fertility treatment
May enhance spermatogenesis and testosterone production in males
May assist in restoring normal gonadal function under medical supervision
Commonly used in assisted reproductive protocols

Possible Side Effects:

Hormonal fluctuations (mood changes, fatigue, headache)
Injection-site discomfort
Risk of ovarian hyperstimulation in females (clinical monitoring required)
Possible breast tenderness or fluid retention
Requires strict medical supervision due to hormonal impact

HMG (75iu)

Table of Contents